Evidence map›Paper›PMID 35127857›Full record

ArticleFrontiers in cardiovascular medicine2021

Myocardial Injury in Multiple Myeloma Patients With Preserved Left Ventricular Ejection Fraction: Noninvasive Left Ventricular Pressure-Strain Myocardial Work.

Zhiyue Liu, Li Zhang, Mei Liu, Fang Wang, Yanqiu Xiong, Zhuoqin Tang, Qian Li, Qiuchen Lu, Shichu Liang, Ting Niu and 1 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06039735 (Cardiac Toxicity and Prognostic Value of New Echocardiographic Indicators in the Treatment of Primary Multiple Myeloma), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06039735 recruitingnot on this mapstarted 2023, after this paper: background citation

Cardiac Toxicity and Prognostic Value of New Echocardiographic Indicators in the Treatment of Primary Multiple Myeloma

TypeobservationalSponsorQilu Hospital of Shandong UniversityRan2023 to 2028Enrolled50ConditionsMultiple MyelomaArmsChemotherapy and/or autologous hematopoietic stem cell transplantation
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Zhiyue LiuDepartment of Cardiology, West China Hospital, Sichuan University, Chengdu, China.
Li ZhangDepartment of Hematology, West China Hospital, Sichuan University, Chengdu, China.
Mei LiuDepartment of Cardiology, West China Hospital, Sichuan University, Chengdu, China.
Fang WangDepartment of Cardiology, West China Hospital, Sichuan University, Chengdu, China.
Yanqiu XiongDepartment of Hematology, West China Hospital, Sichuan University, Chengdu, China.
Zhuoqin TangDepartment of Cardiology, West China Hospital, Sichuan University, Chengdu, China.
Qian LiDepartment of Cardiology, West China Hospital, Sichuan University, Chengdu, China.
Qiuchen LuDepartment of Ultrasound, Mianyang Central Hospital, Mianyang, China.
Shichu LiangDepartment of Cardiology, West China Hospital, Sichuan University, Chengdu, China.
Ting NiuDepartment of Hematology, West China Hospital, Sichuan University, Chengdu, China.
He HuangDepartment of Cardiology, West China Hospital, Sichuan University, Chengdu, China.
Sichuan University · CNWest China Hospital of Sichuan University · CNMianyang Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionOver one-half of patients with multiple myeloma (MM) die of heart failure or arrhythmia. Left ventricular ejection fraction (LVEF) is used to describe left ventricular systolic function. However, depressed LVEF means advanced stage of left ventricular dysfunction in patients with MM. Left ventricular pressure-strain-derived myocardial work (LVMW) is a novel and noninvasive method for evaluating LV function related to LV dynamic pressure load. MW is assessed by LV MW index (LVMWI), constructive work, wasted work, and LV MW efficiency (LVMWE). In this study, we aimed to investigate the value of LVMW in cardiac function assessment and clinical prognosis of MM patients with preserved LVEF.

methodsA total of 72 subjects, including 40 untreated MM patients with preserved EF (including the thick wall and normal wall groups) and 32 non-MM patients, were enrolled in this study. Laboratory data and clinical history of all the patients were collected. All the patients underwent comprehensive echocardiographic examinations and then LVMWI and LVMWE were calculated. Moreover, cardiac adverse events (CAEs) were observed in MM patients treated with bortezomib-based therapy after 6 months and the prognostic value of MW was assessed.

results(1) LV myocardial global work index (GWI), myocardial global work efficiency (GWE), and global longitudinal strain (GLS) were lower in the thick wall group of patients with MM compared with the normal wall group and controls. Cardiac segmental analysis of LVMWI in patients with MM showed an apical sparing pattern; (2) The area under the curve (AUC) of GWE for judging the disease severity based on the Revised International Staging System (R-ISS) was 0.835 (95% CI: 0.684-0.933,

conclusionMM Patients with preserved EF had subclinical LV systolic dysfunction, which was worse in the thick wall group. LVMWI was presented as "apical sparing" in patients with MM. A lower LVGWE may have a predictive value for CAEs in patients with MM after 6 months of follow-up.

Indexed as

cardiac adverse eventscardiac injuryleft ventricular pressure-strain-derived myocardial workmultiple myelomapreserved left ventricular ejection fraction

Identifiers

PMID35127857
PMCPMC8810812
OpenAlexW4206515056

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.